Stephen R. Fussell, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 23,832 shares at $60.13 ($1.4M) on 2018-03-01, disclosed to the SEC on 2018-03-02.
Scheduled sale ($1.4M) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.55 | 12,726 | $771K | 53.6% |
| 2 | $60.13 | 11,106 | $668K | 46.4% |
| Total | $60.35 avg | 23,832 | $1.4M | 100% |
| Filing → |
| ABT | SELL | 2018-02-21 | $3.9M | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.2M | — | Filing → |
| ABT | SELL | 2018-02-21 | $331K | — | Filing → |